Marker Therapeutics Inc (MRKR) — Cash Flow Reinvestment Rate
Latest as of September 2024:
0.00x
Marker Therapeutics Inc (MRKR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2024, reinvesting $1.00 (capex $1.00 ) from operating cash flow of $1.20 Million. See MRKR free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$1.00
Capex + Investments
Operating Cash Flow
$1.20 Million
USD
Capital Expenditures
$1.00
USD
Marker Therapeutics Inc Cash Flow Reinvestment Rate (2001–2001)
Historical reinvestment intensity for Marker Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see MRKR cash flow conversion.
Annual Cash Flow Reinvestment Rate for Marker Therapeutics Inc (2001–2001)
Year-by-year capital reinvestment analysis for Marker Therapeutics Inc. See MRKR financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2001 | 0.00x | $0.00 | $2.38K | $0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow